CD8A and non-small cell lung carcinoma: The role of other components in TME such as CD8 + T cells, regulatory T cells (Treg), programmed death 1 (PD-1), PD-L1 and etc. need to be further investigated to help guiding the application of immunotherapy in patients with NSCLC and BM.